MedTrace Logo

The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)

NCT00924859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2018-10-12

No results posted yet for this study

Summary

The investigators aim to assess the overall accuracy of D-dimer values and FXIII activation peptide (FXIII-AP), using a newly developed ELISA test, to exclude CVT in patients with clinical suspicion of CVT.

Conditions

  • Cerebral Venous Thrombosis

Interventions

OTHER

ELISA Test

assess the overall accuracy of D-dimer values and FXIII activation peptide (FXIII-AP), using a newly developed ELISA test

Sponsors & Collaborators

  • Schweizerische Herzstiftung

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Marcel Arnold, MD Prof. · Dep. of Neurology, Bern University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00924859 on ClinicalTrials.gov